Vonda Rodriguez, PhD, is the Director of Operations for CTSI Accelerator. She provides project management and support to Duke translational research teams to advance research along translational paths.
Dr. Rodriguez holds a BS degree in Chemistry and Biology; a PhD in Analytical Chemistry from University of North Texas; and is a certified project management professional (PMP®). She has 25+ years of progressive drug development experience from pre-IND through post-approval within the pharmaceutical industry. In these roles, she managed resources and complex, cross-functional projects and collaborative teams utilizing traditional, contract, and virtual development strategies for diverse formulations. Her expertise includes: analytical chemistry, chemistry, Manufacturing and Controls (CMC), project and program management, and vendor management. Prior to joining DTRI, Dr. Rodriguez was the director of Analytical Chemistry at Pfizer, Inc. She held project management and pharmaceutical development positions at King Pharmaceuticals, Inc., DSM, and Glaxo. She has managed drug development programs involving solid oral (immediate and extended release, abuse deterrent), liquid oral, topical, and parenteral (injection and lyophilized) dosage forms across a range of therapeutic areas including hypertension, anti-fungal, anti-viral, hypothyroidism, anesthesia, and pain management.